Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-03-08
1997-07-08
McKane, Joseph
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544337, 544358, 544359, 544360, 544372, 544383, 544386, 544387, 544389, 514 85, A61K 31495, C07D24104
Patent
active
056461518
ABSTRACT:
Compounds, compositions and method of treating hyperalgesia comprising a compound of formula I, II, III and IV as defined in the specification.
REFERENCES:
patent: 4065573 (1977-12-01), Lednicer
patent: 4098904 (1978-07-01), Szmuszkovicz
patent: 4145435 (1979-03-01), Szmuszkovicz
patent: 4212878 (1980-07-01), Lednicer et al.
patent: 4359476 (1982-11-01), Kaplan et al.
patent: 4438130 (1984-03-01), Kaplan
patent: 4663343 (1987-05-01), Horwell et al.
patent: 4855316 (1989-08-01), Horwell et al.
patent: 4906655 (1990-03-01), Horwell et al.
Chang An-Chih
DeHaven-Hudkins Diane L.
Farrar John J.
Kruse Lawrence I.
Kumar Virendra
Adolor Corporation
McKane Joseph
LandOfFree
Kappa agonist compounds and pharmaceutical formulations thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Kappa agonist compounds and pharmaceutical formulations thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Kappa agonist compounds and pharmaceutical formulations thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2408990